denosumab

It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss related to long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: REDDY HOLDING GMBH

It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also used to treat bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and bone loss due to long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: SCIENCEPHARMA SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or pressure on the bone marrow) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: SCIENCEPHARMA SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures, pressure on the bone marrow, or the need for surgery/radiotherapy) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH

It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss due to prolonged glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH

It is used in adults to prevent serious complications caused by bone metastases (such as fractures or the need for surgery/radiotherapy) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: MABXIENCE RESEARCH SL

It is used in adults to prevent serious bone complications (such as fractures or pressure on the bone marrow) caused by bone metastases. It is also indicated for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: ZENTIVA K.S.

It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss due to long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED

It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men due to reduced testosterone levels (caused by surgery or therapy for prostate cancer) and for bone loss caused by long-term glucocorticoid treatment in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: MABXIENCE RESEARCH SL

It is used to treat osteoporosis in postmenopausal women and in men at risk of fractures, for bone loss in men with prostate cancer due to hormonal reductions, and for bone loss in at-risk patients caused by long-term glucocorticoid use.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: SANDOZ GMBH

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or pressure on the bone marrow) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: ACCORD HEALTHCARE, S.L.U.

It is used for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men due to reduced testosterone levels (caused by surgery or therapy for prostate cancer) and for bone loss resulting from long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: GEDEON RICHTER PLC

Obodence is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss related to long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: SAMSUNG BIOEPIS NL B.V.

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or the need for surgery) and in the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT

It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss related to long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: ACCORD HEALTHCARE, S.L.U.

It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men due to reduced testosterone levels (caused by surgery or therapy for prostate cancer) and for bone loss resulting from long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection

ATC: M05BX04

Manufacturer: AMGEN EUROPE B.V.

It is used to treat osteoporosis in postmenopausal women and in men at risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss due to long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT

Vevzuo is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or pressure on the bone marrow) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or pressure on the bone marrow) and in the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: SANDOZ GMBH

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or pressure on the bone marrow) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: REDDY HOLDING GMBH

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or pressure on the bone marrow) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: SAMSUNG BIOEPIS NL B.V.

It is used to reduce bone destruction caused by bone metastases (spread of cancer to the bones) or to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: AMGEN EUROPE B.V.

It is used to reduce bone destruction caused by bone metastases (spread of cancer to the bones) or to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Form: solution for injection

ATC: M05BX04

Manufacturer: GEDEON RICHTER PLC

It is used for the treatment of osteoporosis in postmenopausal women and in men at risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss due to long-term glucocorticoid use in patients at risk of fracture.

Form: solution for injection in pre-filled syringe

ATC: M05BX04

Manufacturer: ZENTIVA K.S.